Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy

Joshua J. Short, Angel A. Rivera, Hongju Wu, Mark R. Walter, Masato Yamamoto, J. Michael Mathis, David T. Curiel

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences